作者: Feng Bian , Zheng Li , James Offord , M. Duff Davis , Julie McCormick
DOI: 10.1016/J.BRAINRES.2005.12.084
关键词:
摘要: Pregabalin is a synthetic amino acid compound effective in clinical trials for the treatment of post-herpetic neuralgia, diabetic peripheral neuropathy, generalized anxiety disorder and adjunctive therapy partial seizures epilepsy. However, mechanisms by which pregabalin exerts its therapeutic effects are not yet completely understood. In vitro studies have shown that binds with high affinity to alpha(2)-delta (alpha(2)-delta) subunits (Type 1 2) voltage-gated calcium channels. To assess whether Type major central nervous system (CNS) binding protein vivo, mutant mouse an arginine-to-alanine mutation at 217 (R217A mutation) was generated. Previous site-directed mutagenesis revealed R217A dramatically reduces vitro. this autoradiographic analysis mice, we show substantially specific CNS regions known preferentially express protein, notably neocortex, hippocampus, basolateral amygdala spinal cord. robust throughout where 2 subunit mRNA abundant, such as cerebellum. These findings, conjunction prior data, provide evidence channels CNS. Moreover, distinct localization mutation-resistant (assumed be brain areas subserving different functions suggests identification subunit-specific ligands could further enhance pharmacologic specificity.